Navamedic ASA: Record high quarter with above 50 percent growth
Oslo, 1 November 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces its results for the third quarter of 2023. With growth across the company’s three core product areas, Prescription Drugs (RX), Consumer Health and Hospital, year to date, Navamedic has delivered another record quarter. Revenues for the third quarter amounted to NOK 141 million, corresponding to a 51.9 per cent increase Year-over-Year.The company’s gross margin was 37.6 per cent, down from 42.5 per cent in the third quarter of